Results 61 to 70 of about 1,633 (196)

Could life story work support relational autonomy in advance care planning? Stories from the EARLI project

Australasian Journal on Ageing, Volume 44, Issue 2, June 2025.
Abstract Objectives Advance care planning has evolved from a narrow focus on advance directives completion towards a greater emphasis on ongoing conversations and value clarification. This evolution aligns with a relational perspective on autonomy in a social context.
Ava Karusoo‐Musumeci, Ling Yeoh, Caroline Edwards, Rebecca Walton, Melanie Crabtree, Michelle M. Hilgeman, Craig Sinclair   +6 more
wiley   +1 more source

New insights in the management of pseudomyxoma peritonei

Journal of Surgical Oncology, Volume 130, Issue 6, Page 1316-1325, November 2024.
Abstract While a rare entity, peritoneal pseudomyxoma treatment evolves. Decision‐making criteria improve with imaging development and exploratory laparoscopy. Surgery remains at the core of the therapeutic strategy whatever disease progression. Complete cytoreduction plus hyperthermic intraperitoneal chemotherapy (HIPEC) is standard of care. Iterative
Clément Pastier, I. H. J. T. De Hingh, Diane Goéré   +2 more
wiley   +1 more source

Additional file 1 of Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review

, 2020
Additional file 1. Reporting items for PIPAC.
Magnus Ploug (8433735), Per Pfeiffer (427106), Michael Mortensen (8433741), Martin Graversen (8433738)   +3 more
core   +1 more source

Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy

WIREs Nanomedicine and Nanobiotechnology, Volume 16, Issue 5, September/October 2024.
An overview of key factors in the clinical translation of nanoparticle (NPs) technologies, from composition, scalable production and biological identity through in vitro and in vivo testing, to personalized medicine and patient selection. Abstract Polymeric nanoparticles (NPs), specifically those comprised of biodegradable and biocompatible polyesters,
Giuseppe Longobardi, Thomas Lee Moore, Claudia Conte, Francesca Ungaro, Ronit Satchi‐Fainaro, Fabiana Quaglia   +5 more
wiley   +1 more source

The Implementation of a PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) Program in Portugal

Acta Médica Portuguesa, 2022
N/a.
Tiago Bouça-Machado, Marisa Aral, Sara Meireles, Martin Graversen, Elisabete Barbosa   +4 more
openaire   +3 more sources

Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis

, 2020
Background: Few patients affected by gastric cancer peritoneal metastasis (GCPM) are offered locoregional treatment, despite several proof-of-efficacy trials.
Strippoli A., Inzani F., Abatini C., Rodolfino E., Romano B., Di Giorgio A., El Halabieh M. A., Pacelli F., Vita E., Schena C. A., Rotolo S.   +10 more
core   +2 more sources

PIPAC versus HIPEC: cisplatin spatial distribution and diffusion in a swine model

International Journal of Hyperthermia, 2020
Purpose Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel approach for delivering intraperitoneal chemotherapy and offers perspective in the treatment of peritoneal carcinomatosis.
Axel Davigo, Guillaume Passot, Olivia Vassal, Muriel Bost, Clément Tavernier, Evelyne Decullier, Naoual Bakrin, Mohammad Alyami, Jeanne-Marie Bonnet, Vanessa Louzier, Christian Paquet, Bernard Allaouchiche, Olivier Glehen, Vahan Kepenekian   +13 more
doaj   +1 more source

Research progress in techniques related to pressurized intraperitoneal aerosol chemotherapy (PIPAC)

Holistic Integrative Oncology
Pressurized intraperitoneal aerosol chemotherapy is a novel method for intraperitoneal chemotherapy, with favorable feasibility, safety, and tolerability.
Qiming Fan, Renjie Li, Zifeng Yang, Yong Li   +3 more
doaj   +1 more source

Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma

Therapeutic Advances in Medical Oncology, 2020
Background: Systemic chemotherapy for pancreatic adenocarcinoma (PDAC) and cholangiocarcinoma (CC) with peritoneal metastases (PM) is affected by several pharmacological shortcomings and low clinical efficacy.
Andrea Di Giorgio, Olivia Sgarbura, Stefano Rotolo, Carlo Alberto Schena, Cinzia Bagalà, Frediano Inzani, Andrea Russo, Vito Chiantera, Fabio Pacelli   +8 more
doaj   +1 more source

Radiologist Checklist for Selecting Patients to Undergo PIPAC (Pressurized IntraPeritoneal Aerosol Chemotherapy)

, 2021
Peritoneal carcinomatosis frequently occurs in advanced gastrointestinal and gynecological cancers. As factors such as poor drug uptake and distribution cause chemotherapy to be less effective, alternative therapies have been explored. Introduced in 2013,
Elena Rodolfino, Roberto Iezzi, Camilla Panico, Giacomo Avesani, Riccardo Manfredi, Andrea Di Giorgio, Benedetta Gui, Alessia Ilot, Margo’ Di Marco, Antonia Strippoli, Fabio Pacelli   +10 more
core   +1 more source